Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989
Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Seizures in Progressive Supranuclear Palsy
Neurol 39:138-140, Nygaard,T.G.,et al, 1989
Pulmonary Function in Parkinson's Disease
JNNP 52:329-333, Hovestadt,A.,et al, 1989
Cortical Lewy Body Dementia:Clinical Features and Classification
JNNP 52:185-192, Gibb,W.R.G.,et al, 1989
Did Leonardo Describe Parkinson's Disease?
NEJM 320:593, Calne,D.B.,et al, 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
The Olfactory and Cognitive Deficits of Parkinson's Disease:Evidence for Independence
Ann Neurol 25:166-171, Doty,R.L.,et al, 1989
Special Report of Fetal Tissue Transplants
National Right to Life News, January 22, 16:1-18989., , 1989
Multicenter Study of Autologous Adrenal Medullary Transplantation to Corpus Striatum in Pts with Advanced Parkinson's Dis
NEJM 320:337-341, Goetz,C.G.,et al, 1989
Autopsy Findings in a Patient Who Had an Adrenal-To-Brain Transplant for Parkinson's Disease
Neurol 39:235-238, Peterson,D.I.,et al, 1989
MR Imaging of Parkinson Disease with Spin-Echo and Gradient-Echo Sequences
AJR 152:159-165, Braffman,B.H.,et al, 1989
A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989
Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989
Frozen Shoulder and Other Shoulder Disturbances in Parkinson's Disease
JNNP 52:63-66, Riley,D.,et al, 1989
Antecollis in Parkinsonism
Lancet 1:1320-1321, Jorens,P.G.,et al, 1989
Observations on the Applicability of the Wartenberg Pendulum Test to Healthy, Elderly Subjects
JNNP 51:1171-1177, Brown,R.A.,et al, 1988
Diffuse Lewy Body Disease and Progressive Dementia
Neurol 38:1520-1528, Burkhardt,C.R.,et al, 1988
Hand Contractures in Parkinson's Disease
JNNP 51:1221-1223, Kyriakides,T.&Hewer,R.L., 1988
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Risk Factors for Progression in Parkinson's Disease
Neurol 38:1841-1844, Goetz,C.G.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988
Amitriptyline in the Treatment of Headache in Patients with Parkinson's Disease:Double-Blind Study
Neurol 38:1720-1721, Indaco,A.&Carrieri,P.B., 1988
Dystonic-Parkinsonian Syndrome after Cyanide Poisoning:Clinical and MRI Findings
JNNP 51:1345-1348, Carella,F.,et al, 1988
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
Adoption and Genetic Prediction for Huntington's Disease
Lancet 2:1069-1070, Morris,M.,et al, 1988
Risk Factors for Progressive Supranuclear Palsy
Neurol 38:1546-1552, Davis,P.H.,et al, 1988
Parkinsonian Syndrome Caused by a Tumour of the Left Supplementary Motor Area
JNNP 51:730-731, Straube,A.&Sigel,K., 1988
A Comparison of Clinical and Pathological Features of Young-and Old-Onset Parkinson's Disease
Neurol 38:1402-1406, Gibb,W.R.G.&Lees,A.J., 1988
Drug-Induced Alzheimerism
Arch Neurol 45:356-357, Kurlan,R.&Como,P., 1988
Neonatal Myasthenia Gravis:A New Clinical & Immunologic Appraisal on 30 Cases
Neurol 38:138-142, Morel,E.,et al, 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Autonomic Nervous Function in Huntington's Disease
Arch Neurol 45:309-312, DenHeijer,J.C.,et al, 1988
Predictive Testing for Huntington's Disease with Use of a Linked DNA Marker
NEJM 318:535-542, Meissen,G.J.,et al, 1988
Does Levodopa Aggravate Parkinson's Disease
Neurol 38:1410-1416, Blin,J.,et al, 1988
Duodenal and Gastric Delivery of Levodopa in Parkinsonism
Ann Neurol 23:589-595, Kurlan,R.,et al, 1988
Long-Term Duodenal Infusion of Levodopa for Motor Fluctuations in Parkinsonism
Ann Neurol 24:87-89, Sage,J.I.,et al, 1988
Hemiparkinsonism with Hemiatrophy
Neurol 38:527-530, Buchman,A.S.,et al, 1988
Familial Parkinsonism, Apathy, Weight Loss & Central Hypoventilation:Successful Long-Term Management
Neurol 38:637-639, Roy,E.P.,et al, 1988
Parkinson's Disease in a Nationwide Twin Cohort
Neurol 38:1217-1219, Marttila,R.J.,et al, 1988
Comparison of the Prevalence of Parkinson's Disease in Black Populations in the Rural US & Nigeria
Neurol 38:645-646, Schoenberg,B.S.,et al, 1988
Olfactory Dysfunction in Parkinsonism:A General Deficit Unrelated to Neurologic Signs, Disease Stage, or Duration
Neurol 38:1237-1244, Doty,R.L.,et al, 1988
Lack of Association Between Essential Tremor and Parkinson's Disease
Ann Neurol 24:23-26, Cleeves,L.,et al, 1988
Transplantation of Fetal Substantia Nigra & Adrenal Medulla to the Caudate Nucleus in Two Pts with Parkinson'sDisease. Editorial
NEJM 319:370-371, , 1988
Adrenal and Nigral Transplants for Parkinson's Disease
BMJ 296:1211-1212, Pearce,J.M.S., 1988
Ethics of Fetal Brain Cell Transplants
BMJ 296:1212-1213, Gillon,R., 1988
Embryos and Parkinson's Disease
Editorial, Lancet 1:10871988., , 1988
Neural & Adrenal Medullary Transplants as a Treatment for Parkinson's & Other Neurodegenerative Disorders
NeuroView 4:May/June, Lieberman,A.,et al, 1988